" We can interrogate the fetal genome to identify smaller pieces of DNA that are either added or subtracted , and many of these can cause disease , " said Ronald J. Wapner of Columbia University , who is leading a $ 3.3 million federally funded study that is starting to evaluate the technology in 4,000 pregnancies .